Krsnaa Diagnostics Limited · NSE:KRSNAA

Krsnaa Diagnostics — Q1 FY2026 Earnings Presentation

30 slides from Krsnaa Diagnostics's earnings presentation, Aug 11, 2025

  1. Slide 1: Regulation 30 intimation letter to stock exchanges

    Date: August 11, 2025 Ref. No.: KDL/SE/041/2024-25 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400

  2. Slide 2: Q1 FY2026 Result Presentation

    Q1 FY2026 Result Presentation One of INDIA’S LARGEST Integrated Diagnostic Service Provider

  3. Slide 3: Disclaimer

    Disclaimer This presentation contains statements that are “forward-looking statements”, including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements pertaining to Krsnaa Diagnostics’ future business developments and economic performance.

  4. Slide 4: Krsnaa Diagnostics Limited

    DIAGNOSTICS Krsnaa Diagnostics Limited

  5. Slide 5: Krsnaa Diagnostics At a Glance

    185 70 CT/ MRI Centres 3,500+ Million+ Patient Collectionn Centres Patients Served Since Inception Krsnaa Diagnostics At a Glance 120 18 Pathology Labs States/UT Presence in India One of India’s largest NABH accredited Krsnaa Diagnostics is one of the fastest tele-radiology reporting hub with growin

  6. Slide 6: Our Strengths

    Our Strengths The only listed company in PPP (Public Private 18 states and union Partnership) space with bid territories with penetration till ~70 Mn+ patients served since win ratio of 75%+ tier-II and tier-III towns inception Integrated diagnostic services Quality diagnostic services at Operationa

  7. Slide 7: Retail Expansion

    Retail Expansion Retail Revenue Contribution to Group Revenue Retail Revenue (mn) Q1 FY25 Q1 FY26 1% 6% 118 RPL RPL Krsnaa Krsnaa 15 99% 94% Q1 FY25 Q1 FY26 Segment Retail Revenue Mix No. of Touch Points Q1 FY25 Q1 FY26 2,414 10% 34% B2C B2C B2B B2B 66% 362 90% Q1 FY25 Q1 FY26 © Krsnaa Diagnostics L

  8. Slide 8: Q1 FY26 Financial Performance

    Q1 FY26 Financial Performance Particulars Q1 FY26 Q1 FY25 Growth Particulars Q1 FY26 Q1 FY25 Growth Revenue 1,930 1,702 13% EPS 6.3 5.5 14% EBIDTA 524 442 19% No. of Patient Served 5.0 4.8 4% EBIDTA Margin 27% 26% 120 bps No. of Test performed 15.8 15.3 3% NABL PAT 205 179 15% Accreditation 54 23 13

  9. Slide 9: Q1 FY26 – Centre Growth

    Q1 FY26 – Centre Growth CT Centre MRI Centre Tele- Radiology Centre 145 Upon completion of our existing 131 40 order book, we will have 37 1,501 200+ CT/MRI centres, Radiology 1,434 cementing our position as one of Asia’s Largest Radiology Players. Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Ref

  10. Slide 10: Competitive Advantages

    Competitive Advantages

  11. Slide 11: Driving Excellence Through Quality

    Driving Excellence Through Quality India’s 1st CAP Accredited Lab India’s 1st NABH Accredited at Government Facility Tele-Radiology Hub 54 31 National Accreditation for Board of National Accreditation Board for testing's & Calibration Laboratories Hospitals & Healthcare Providers We are committed to

  12. Slide 12: Our Pricing - Everyone Can Afford

    Our Pricing - “Everyone Can Afford” % lower from Segment Test Competition 1 Competition 2 Competition 3 Krsnaa competitors Radiology CT Brain 4,500 4,500 3,500 880 (75)% Radiology MRI Brain 8,000 8,250 7,000 1,340 (81)% Pathology CBC 250 250 200 37 (82)% Pathology Blood Sugar 85 80 70 20 (71)% Patho

  13. Slide 13: Presence - PAN India

    Presence - PAN India Well Diversified Regional Revenue Mix 17% 30% Q1 FY26 40% 13% West South North East India map for representation only, not to scale © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 12

  14. Slide 14: Growth Levers

    Growth Levers Captive Cost Skilled Human Robust Synergistic Long Tenure Consumer Leadership Resource IT Infrastructure Infrastructure Predictable & Long- • Government OPD & Cost Optimisation: • 450+ qualified Advanced Fully Pathology: term Business outlook: IPD patients doctors Integrated IT system:

  15. Slide 15: New Centres

    DIAGNOSTICS New Centres

  16. Slide 16: State-Of-Art Infrastructure Enabling Reliable Diagnostics

    State-Of-Art Infrastructure Enabling Reliable Diagnostics MRI- Gwalior, Madhya Pradesh CT- Murtizapur, Maharashtra Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 15

  17. Slide 17: State-Of-Art Infrastructure Enabling Reliable Diagnostics

    State-Of-Art Infrastructure Enabling Reliable Diagnostics CT- Ranchi, Jharkhand Ranchi Centre, Jharkhand Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 16

  18. Slide 18: State-Of-Art Infrastructure Enabling Reliable Diagnostics

    State-Of-Art Infrastructure Enabling Reliable Diagnostics CT/ MRI Centre- Indira Gandhi Hospital, Delhi Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 17

  19. Slide 19: ESG Initiatives

    DIAGNOSTICS ESG Initiatives

  20. Slide 20: ESG Initiatives

    ESG Initiatives Solar system capable of ~20,000 hours Learning and Using Biodegradable bags generating 80 KW of green energy development programs for employees for BMW Workflow digitization eliminated Effluent treatment plants for 2,500+ Lives touched the monthly need for 10,000+ paper wastewater re

  21. Slide 21: Krsnaa Retail - RPL

    Krsnaa Retail - RPL

  22. Slide 22: Krsnaa Retail – RPL

    Krsnaa Retail – RPL • Focused Expansion: Strengthening presence in 4 high-potential states – Maharashtra, Assam, • Leveraging existing Odisha, Punjab infrastructure for Radiology & Pathology, both for better • Integrated Services: Adding • Retail Network: 300 pathology to radiology patient care and

  23. Slide 23: Growth in Retail Business

    Growth in Retail Business Retail Network Key Geographies 741 2,414 798 1,673 267 875 608 Maharashtra Punjab Assam Odisha Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 India map for representation only, not to scale “Touch points increased by 741 across 4 states in Q1 FY26” © Krsnaa Diagnostics Ltd. All Rights Res

  24. Slide 24: Foray into Retail: In-shop Branding

    Foray into Retail In-shop Branding © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 23

  25. Slide 25: Preventive Healthcare - Wellness Packages For All

    Foray into Retail Preventive Healthcare - Wellness Packages For All © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 24

  26. Slide 26: Foray into Retail: Health Checkup Camp/Awareness

    Foray into Retail Health Checkup Camp/Awareness © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 25

  27. Slide 27: Awards & Accolades

    Awards & Accolades Best Diagnostic Leading HR Lab Chain of the Transformation year (West) Award © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2025 26

  28. Slide 28: Financial Performance

    DIAGNOSTICS Financial Performance

  29. Slide 29: Consolidated Financial Performance

    Consolidated Financial Performance Particulars Q1 FY 26 Q1 FY 25 Q4 FY 25 FY 25 FY 24 Amount % Amount % Amount % Amount % Amount % Revenue from operations 1,930 1,702 1,861 7,172 6,196 Expenses Cost of Material Consumed 474 25% 429 25% 415 22% 1,693 24% 1,410 23% Employee benefits expense 350 18% 32

  30. Slide 30: Krsnaa Diagnostics

    For further information please contact Krsnaa Diagnostics Vivek Jain, Head- Investor Relations head.investor@krsnaa.in Contact: +91 74107 00645 https://krsnaadiagnostics.com

Krsnaa Diagnostics — Q1 FY2026 Earnings Presentation on 6ix